Tricuspid valve complication following leadless pacemaker implantation requiring device extraction
The last decade has seen growing interest in leadless cardiac pacing systems. The appeal of leadless pacemaker (LP) implantation is potentially avoiding complications associated with conventional transvenous systems, such as infection, lead fracture, and tricuspid valve (TV) dysfunction.1 However, evidence to date has provided mixed results as to whether leadless systems do, in fact, reduce the risk of TV dysfunction.2,3 Furthermore, there are limited data regarding the feasibility and challenges associated with LP extraction.
